Cerebrovascular
diseases include some of the most common and devastating disorders: ischemic
stroke and hemorrhagic stroke. According to the World Health Organization, 15
Million people suffer stroke worldwide each year. Of these, 5 Million die and
another 5 Million are permanently disabled. Stroke is the third leading cause
of death in the United States. More than 140,000 people die each year from
stroke in the United States. The incidence of cerebrovascular diseases
increases with age, and the number of strokes is projected to increase as the
elderly population grows, with a doubling in stroke deaths in the United States
by 2030.
Drivers
& Restraints
Market
growth can be attributed to factors such as rising prevalence of
cerebrovascular disease and its associated risk factors, rise in the number of
aging population, increasing knowledge of the symptoms of aneurysms and related
diseases among patients, next generation of device platforms enters the market,
long-term clinical data become available, appropriate treatment guidelines and
reimbursement rates are established. Rapid advances in the field of
neuroendovascular devices and development of minimally invasive techniques have
greatly expanded the market. High cost of treatment, unmet needs, scarcity of
skilled neurosurgeons is restraining the growth of neuroendovascular coil &
non-coil devices market.
Device
Insights
Coil
represented the largest single category of products and accounted for share in
2015. However, growth rate has slowed down in the segment which is being
challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal
device. These three major devices grabbed the market share of in 2015. It is
expected that Coil will lead the neuroendovascular coil & non-coil devices
market with market share by the end of
2021.
Country
Insights
United
States is seen as the dominant player in the neuroendovascular coil &
non-coil devices market. Emerging economies of India, China and Japan in the
Asia-Pacific region and Latin American countries such as Brazil is slated to
witness the highest growth in the forecasted period. The growth of the
Asia-Pacific market is driven by improving healthcare facilities, gross
domestic product (GDP) and increasing government investment.
Company
Insights
Prudent
analysis has been done on the competitor’s part, where four major players grab
of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes
are the key influencers with their products in the neuroendovascular coil &
non-coil devices market. New releases, merger & acquisitions,
collaborations and extending distribution networks are few important factors
for their dominance.
The
research report presents a comprehensive assessment of the market and contains
thoughtful insights, facts, historical data, and statistically supported and
industry–validated market data. It also contains projection using a suitable
set of assumptions and methodologies. The research report provides analysis and
information according to categories such as market segments, diseases,
geographies, companies, price trend, pipeline products, type of coil &
non-coil devices and competitive landscape. The report concludes with the
profiles of major players in the global neuroendovascular coil & non-coil
devices market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major
market players are evaluated on various parameters such as company overview,
product portfolio, and sales figures of neuroendovascular coil & non-coil
devices segment from 2012 to 2021. The report also entails major drivers and
challenges of neuroendovascular coil & non-coil devices market.
Market
Segmentation
Neuroendovascular
coil & non-coil devices market can be segmented based on
- Device Type
- Disease Type
- Company
- Geography
Based
on Device, the global neuroendovascular coil & non-coil devices market can
be segmented as follows:
- Coil
- Carotid Stent
- Clot Removal
- Liquid Embolic
- Coil Assist Balloon
- Coil Assist Stent
- Flow Diverter Stent
- Micro wire/Catheter
Based
on Disease, the global neuroendovascular coil & non-coil devices market can
be segmented as follows:
- Aneurysm
- Intracranial Atherosclerotic Disease (ICAD)
- Ischemic Stroke
- Arteriovenous Malformation(AVM)
Based
on Geography, the global neuroendovascular coil & non-coil devices market
can be segmented as follows:
- United States
- France
- Germany
- Italy
- Spain
- United Kingdom
- Japan
- China
- India
- Brazil
Based
on Company, the global neuroendovascular coil & non-coil devices market can
be segmented as follows:
- Stryker
- Medtronic
- MicroVention (Terumo Corporation)
- De Puy Synthes
Spanning
over 119 pages, “Global
Neuroendovascular Coil and Non-Coil Devices Market - Growth, Trends and
Forecasts (2016 - 2021)” report covers Executive Summary, Global –
Neuroendovascular Coil & Non-Coil Devices Market & Forecast (2009 –
2021), Global – Neuroendovascular Coil & Non-Coil Devices Market Share
Outlook, Global Neuroendovascular Coil & Non-Coil Devices Market – Device
Segmentation (2009 – 2021), Global Neuroendovascular Coil & Non-Coil
Devices Market – Geographical Segmentation (2013 – 2021), Global
Neuroendovascular Coil & Non-Coil Devices Market – Disease Category
Segmentation (2013– 2021), Neuroendovascular Coil & Non-Coil Devices –
Price Analysis, Neuroendovascular Coil & Non-Coil Devices Analysis – Major
Neuroendovascular Products, Recent FDA Approval Products, Pipeline Products,
Promising New Products, Competitive Landscape of Major Neuroendovascular
Companies, Key Companies Analysis, Neuroendovascular Coil & Non-Coil
Devices Market – Growth Drivers, Neuroendovascular Coil & Non-Coil Devices
Market – Challenges,
For
more information Visit at: http://mrr.cm/3TM
Find all Medical Devices
Reports at - http://www.marketresearchreports.com/medical-devices
No comments:
Post a Comment
Note: only a member of this blog may post a comment.